Bills · HR 6009
IN COMMITTEE· 119TH CONGRESS
House BillHR 6009Armed Forces and National Security
Defense Biotechnology Strategy Act
INTRO NOV 10· LAST ACTION NOV 10
READING
3MIN
COSPONSORS
2
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThis bill matters because biotechnology is advancing rapidly, and these changes have significant implications for national security, ranging from new medical treatments for soldiers to advanced materials and even biological threats. By requiring a comprehensive strategy, the bill aims to ensure the U.S. military is prepared to both effectively use these emerging technologies for defense and adequately defend against their misuse.
If this bill becomes law, the Department of Defense will be compelled to formally assess its current approach to biotechnology and develop a forward-looking plan. This could lead to increased investment in biotech research, new defense capabilities, and stronger international partnerships. If it doesn't pass, the DoD might continue to address these issues in a less coordinated or comprehensive way, potentially falling behind adversaries or missing opportunities for innovation in this critical field.
KEY PROVISIONS
5AI-extractedPROVISION 01
Requires the Department of Defense to develop a strategy on the national security implications of emerging biotechnologies.
This ensures a focused, high-level plan for integrating cutting-edge biological science into defense planning and operations.
PROVISION 02
Directs the strategy to include how the Department will expand a network of commercial facilities for manufacturing critical biotech defense products.
This aims to secure and strengthen the supply chain for essential biotechnology items needed for national defense.
PROVISION 03
Mandates reviewing and updating military specifications to incorporate biotechnology-based products and calls for plans to enter into advance market commitments for these products.
This ensures the military adopts modern biological technologies and encourages their development by guaranteeing future purchases.
PROVISION 04
Requires the strategy to detail how to include military-relevant biotechnology applications into wargaming and exercises.
This helps prepare military leaders and planners for future conflicts involving advanced biological capabilities and threats.
PROVISION 05
Asks for plans on how the Department can work with NATO countries to combine their demand and purchasing power for biotechnology products and integrate research.
This promotes international collaboration and strengthens the collective defense posture regarding biotechnology among allies.
SPONSORSHIP
1 + 2
D· Pennsylvania
YRS IN OFFICE
7
BILLS LED
36
COSPONSOR BREAKDOWNBIPARTISAN · 0%
DEM 0 REP 2 IND 0
ACTION TIMELINE
2 EVENTSNOV 10
Introduced in House
NOV 10
Referred to the Committee on Armed Services, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
BILL INFO
TypeHouse Bill
NumberHR 6009
Congress119th
StatusIn Committee
IntroducedNov 10, 2025
Last actionNov 10, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · ARMED SERVICES COMMITTEE · INTRODUCED NOV 10, 2025
House BillHR 6009Armed Forces and National Security
Defense Biotechnology Strategy Act
INTRODUCED NOV 10, 2025· LAST ACTION NOV 10, 2025
PASSAGE CHANCES
—%
READING
3 min
COSPONSORS
2
COMPLEXITY
Moderate
